Journal article · 2025 · Open access

Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis

Isobel McLachlan, Chris Robertson, Kirsty Morrison, Ross McQueenie, Safraj Shahul Hameed, Cheryl Gibbons, Rachael Wood, Rachel Merrick, Louisa Pollock, Antonia Ying Wai Ho, Ting Shi, Thomas Williams and 4 more

The Lancet Infectious Diseases, 26(4), 362–373 · Published 29 November 2025 · DOI 10.1016/s1473-3099(25)00624-3

Open PDFView at the publisherCite this paper

In brief

“Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis” is a 2025 journal article by Isobel McLachlan and 15 co-authors, published in The Lancet Infectious Diseases. OpenAlex counts 38 citations as of 16 November 2026. It is open access: the full text is free to read at medRxiv.

Citations
38
Most cited in
2026 (37)
Field-weighted impact
20.77
References
17
Authors
16

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

McLachlan, I., Robertson, C., Morrison, K., McQueenie, R., Hameed, S. S., Gibbons, C., Wood, R., Merrick, R., Pollock, L., Ho, A. Y. W., Shi, T., Williams, T., Sheikh, A., McMenamin, J., Ghebrehewet, S., & Marsh, K. (2025). Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis. The Lancet Infectious Diseases, 26(4), 362–373. https://doi.org/10.1016/s1473-3099(25)00624-3

MLA 9

McLachlan, Isobel, et al. “Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis.” The Lancet Infectious Diseases, vol. 26, no. 4, 2025, pp. 362–373. https://doi.org/10.1016/s1473-3099(25)00624-3.

Chicago

McLachlan, Isobel, Chris Robertson, Kirsty Morrison, Ross McQueenie, Safraj Shahul Hameed, Cheryl Gibbons, Rachael Wood, et al. 2025. “Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis.” The Lancet Infectious Diseases 26 (4): 362–373. https://doi.org/10.1016/s1473-3099(25)00624-3.

Harvard

McLachlan, I. et al. (2025) ‘Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis’, The Lancet Infectious Diseases, 26(4), pp. 362–373. doi:10.1016/s1473-3099(25)00624-3.

IEEE

I. McLachlan et al., “Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis,” The Lancet Infectious Diseases, vol. 26, no. 4, pp. 362–373, 2025, doi: 10.1016/s1473-3099(25)00624-3.

BibTeX

@article{mclachlan2025effectiveness,
  title     = {{Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis}},
  author    = {McLachlan, Isobel and Robertson, Chris and Morrison, Kirsty and McQueenie, Ross and Hameed, Safraj Shahul and Gibbons, Cheryl and Wood, Rachael and Merrick, Rachel and Pollock, Louisa and Ho, Antonia Ying Wai and Shi, Ting and Williams, Thomas and Sheikh, Aziz and McMenamin, Jim and Ghebrehewet, Sam and Marsh, Kimberly},
  journal   = {The Lancet Infectious Diseases},
  year      = {2025},
  volume    = {26},
  number    = {4},
  pages     = {362--373},
  doi       = {10.1016/s1473-3099(25)00624-3},
  url       = {https://doi.org/10.1016/s1473-3099(25)00624-3}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Epidemiology › Respiratory viral infections research

  • respiratory syncytial virus
  • RSVpreF vaccine
  • maternal immunization
  • vaccine effectiveness
  • lower respiratory tract infection
  • infant hospitalization
  • Scotland
  • real-world effectiveness

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

McLachlan, I., Robertson, C., Morrison, K., McQueenie, R., Hameed, S. S., Gibbons, C., Wood, R., Merrick, R., Pollock, L., Ho, A. Y. W., Shi, T., Williams, T., Sheikh, A., McMenamin, J., Ghebrehewet, S., & Marsh, K. (2025). Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis. The Lancet Infectious Diseases, 26(4), 362–373. https://doi.org/10.1016/s1473-3099(25)00624-3

How many times has this paper been cited?

38 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at medRxiv: sign in and open the PDF from this page.

Who wrote this paper?

Isobel McLachlan, Chris Robertson, Kirsty Morrison, Ross McQueenie, Safraj Shahul Hameed, Cheryl Gibbons, Rachael Wood, Rachel Merrick, Louisa Pollock, Antonia Ying Wai Ho, Ting Shi, Thomas Williams and 4 more.

What is the DOI of this paper?

10.1016/s1473-3099(25)00624-3, permanently at https://doi.org/10.1016/s1473-3099(25)00624-3. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.